Pet King Brands

Pet King Brands is a prominent player in the veterinary healthcare sector, specializing in the development and commercialization of enzymatic treatments for companion animals. The company is most recognized for its Zymox and Oratene brands, which provide antibiotic-free alternatives for managing ear infections, skin conditions, and oral health. Their core technology, the LP3 Enzyme System, leverages a synergistic blend of lactoperoxidase, lysozyme, and lactoferrin to combat resistant microbes and biofilms. Headquartered in Illinois, the company has established a significant presence in both the professional veterinary channel and the retail pet specialty market. In late 2021, Pet King Brands was acquired by Compana Pet Brands, further integrating its specialized enzymatic solutions into a broader animal health portfolio.